Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer

PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JCO Clin Cancer Inform
Hoofdauteurs: Rocque, Gabrielle B., Gilbert, Aidan, Williams, Courtney P., Kenzik, Kelly M., Nakhmani, Arie, Kandhare, Pravinkumar G., Bhatia, Smita, Burkard, Mark E., Azuero, Andres
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2020
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/
https://ncbi.nlm.nih.gov/pubmed/32479187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items